Allspring Global Investments
OVID icon

Allspring Global Investments’s Ovid Therapeutics OVID Stock Holding History

Allspring Global Investments’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.6K Hold
11,262
– – ﹤0.01% 1765
2026
Q1 		$23.8K Hold
11,262
– – ﹤0.01% 1696
2025
Q4 		$18.7K Hold
11,262
– – ﹤0.01% 1656
2025
Q3 		$15.4K Sell
11,262
-27,025
-71% -$23.4K ﹤0.01% 1613
2025
Q2 		$12.1K Buy
+38,287
New +$11.5K ﹤0.01% 1607
2023
Q4 		– Sell
-6,294
Closed -$24.2K – 2591
2023
Q3 		$24.2K Buy
+6,294
New +$22.6K ﹤0.01% 2468

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Allspring Global Investments's OVID Position: Q2 2026 in Review

Allspring Global Investments held its Ovid Therapeutics (OVID) position steady in Q2 2026 at 11,262 shares worth $30.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1765.

Allspring Global Investments first reported a position in OVID in Q3 2023 and has held it in 6 quarters since. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Allspring Global Investments held 11,262 shares of Ovid Therapeutics worth $30.6K as of Q2 2026.
  • Allspring Global Investments left its Ovid Therapeutics share count unchanged in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1765 holding.
  • Allspring Global Investments first reported a position in Ovid Therapeutics in Q3 2023 and has held it in 6 quarters since.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.